Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.23.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Jan. 31, 2021
Cash flow from operating activities:      
Net loss $ (55,742) $ (111,470) $ (37,970)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization expense 12,051 8,058 5,690
Bad debt expense 4,079 (186) 689
Stock-based compensation, net of amounts capitalized 55,517 50,131 43,883
Litigation settlement 0 12,000 0
Non-cash interest paid in kind and discount amortization 0 3,266 5,523
Non-cash lease expense 6,588    
Deferred income taxes 166 235 110
Other non-cash items, net (2,697) (1,272) (712)
Changes in operating assets and liabilities:      
Accounts receivable (44,751) (47,094) (9,781)
Prepaid expenses and other current assets 29,092 (8,220) (28,709)
Other non-current assets (24,376) (6,764) (7,082)
Accounts payable 14,463 (1,095) 6,077
Operating lease liabilities (6,342)    
Accrued expenses and other current liabilities 6,688 25,510 12,286
Litigation settlement (12,000) 0 0
Deferred revenue 41,465 43,404 17,511
Other liabilities 2,459 575 (204)
Net cash provided by (used in) operating activities 26,660 (32,922) 7,311
Cash flow from investing activities:      
Purchases of marketable securities (816,708) (267,826) (212,973)
Sales of marketable securities 2,838 56,652 0
Maturities of marketable securities 636,825 211,555 0
Purchases of property and equipment (6,091) (6,148) (2,701)
Capitalized internal-use software (10,358) (6,258) (3,783)
Acquisitions, net of cash acquired 0 (3,625) 0
Net cash used in investing activities (193,494) (15,650) (219,457)
Cash flow from financing activities:      
Proceeds from issuance of common stock upon initial public offering, net of underwriting discounts, commissions and other offering costs 0 275,973 0
Proceeds from issuance of convertible preferred stock, net of issuance costs 0 0 191,752
Proceeds from Senior subordinated secured convertible notes 0 0 73,425
Proceeds from issuance of stock warrants 0 0 7,639
Repurchase of preferred stock 0 0 (12,416)
Deemed dividend on preferred stock 0 0 (600)
Proceeds from short-term borrowings 0 0 49,973
Repayments of short-term borrowings 0 0 (49,973)
Payments of debt and equity issuance costs 0 0 (475)
Repurchase of common stock 0 0 (5,874)
Proceeds from issuance of common stock upon exercise of stock options 24,740 20,054 16,333
Proceeds from issuance of common stock upon ESPP purchase 10,231 7,105 0
Net cash provided by financing activities 34,971 303,132 269,784
Effect of exchange rate fluctuations on cash and cash equivalents (1,176) (1,171) (71)
Net change in cash and cash equivalents (133,039) 253,389 57,567
Cash and cash equivalents at beginning of period 321,426 68,037 10,470
Cash and cash equivalents at end of period 188,387 321,426 68,037
Supplemental disclosure of cash flow information:      
Cash paid for income taxes, net of refunds 6,644 3,458 3,187
Cash paid for interest 0 0 224
Supplemental disclosure for non-cash investing and financing:      
Right-of-use assets obtained in exchange for operating lease liabilities 8,948    
Accrued purchases of property and equipment 1,445 216 382
Stock-based compensation expense capitalized in internal-use software 2,540 696 0
Net exercise of common stock warrants 0 18 0
Accrued for asset retirement obligations 0 0 476
Common stock issued in exchange for other non-cash assets $ 0 $ 0 $ 5,000